ArticleReproductive sciences (Thousand Oaks, Calif.)2025
ATF2-mediated Transcriptional Activation of USP4 Stabilizes KMT2A Protein and Promotes Trophoblast Dysfunction.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preeclampsia (PE) is a severe and prevalent complication of pregnancy, characterized by insufficient trophoblast invasion, placental hypoxia, and systemic inflammation, which collectively represent the central pathological mechanisms underlying the disease. The molecular mechanism involving activating transcription factor 2 (ATF2), ubiquitin-specific peptidase 4 (USP4), and lysine methyltransferase 2 A (KMT2A) in hypoxia/reoxygenation (H/R)-treated trophoblast cells (HTR-8/SVneo) is explored, aiming to provide a novel theoretical basis for therapeutic strategies against PE. An in vitro H/R model was established using HTR-8/SVneo trophoblast cells to simulate PE pathophysiology. The expression levels of mRNA and protein were evaluated using RT-qPCR and western blotting, respectively. The proliferation, apoptosis, and invasion of cells were assessed using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 5-ethynyl-2'-deoxyuridine (EdU), flow cytometry, and transwell assays. Ferroptosis-related markers were measured using commercial kits. The interaction between USP4 and KMT2A was determined by co-immunoprecipitation (Co-IP) and ubiquitination assays. Dual-luciferase reporter and chromatin immunoprecipitation (ChIP) assays were employed to investigate the binding of ATF2 to the USP4 promoter. KMT2A knockdown enhanced hypoxia/reoxygenation (H/R)-induced proliferation and invasiveness and suppressed apoptosis and ferroptosis in HTR-8/SVneo cells. The deubiquitinase USP4 stabilized KMT2A protein expression through deubiquitination. Overexpression of KMT2A reversed the impacts of USP4 silencing on H/R-mediated cellular injury and ferroptosis. Mechanistically, ATF2 transcriptionally activated USP4 expression. Furthermore, USP4 upregulation rescued the influences of ATF2 depletion on H/R-induced HTR-8/SVneo cell injury and ferroptosis. ATF2 activated USP4 transcription, which subsequently deubiquitinated and stabilized KMT2A protein expression, thereby influencing the progression of PE.
Indexed as
Identifiers
40804593What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.